Tista Roy Chaudhuri, Ph.D.
Affiliations: | 2012 | Roswell Park . Biophysics | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Pharmacology, NanotechnologyGoogle:
"Tista Roy Chaudhuri"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert M. Straubinger | grad student | 2012 | SUNY Buffalo (BME Tree) | |
| (Strategies for improving chemotherapeutic delivery to solid tumors mediated by vascular permeability modulation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lin Q, Serratore A, Niu J, et al. (2024) Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 73: 101064 |
| Roy Chaudhuri T, Lin Q, Stachowiak EK, et al. (2024) Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Roy Chaudhuri T, Straubinger NL, Pitoniak RF, et al. (2015) Tumor-priming Smoothened inhibitor enhances deposition and efficacy of cytotoxic nanoparticles in a pancreatic cancer model. Molecular Cancer Therapeutics |
| Roy Chaudhuri T, Arnold RD, Yang J, et al. (2012) Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. Pharmaceutical Research. 29: 3312-24 |